CN1356117A - Capsule 'Tangniaoshenkang' for treating diabetes - Google Patents
Capsule 'Tangniaoshenkang' for treating diabetes Download PDFInfo
- Publication number
- CN1356117A CN1356117A CN 01100442 CN01100442A CN1356117A CN 1356117 A CN1356117 A CN 1356117A CN 01100442 CN01100442 CN 01100442 CN 01100442 A CN01100442 A CN 01100442A CN 1356117 A CN1356117 A CN 1356117A
- Authority
- CN
- China
- Prior art keywords
- fructus
- capsule
- radix
- tangniaoshenkang
- treating diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese emdicine "Tangniaoshenkang capsule" for treating diabetes and nephrosis is prepared from 18 Chinese-medicinal materials including madder, tribulus fruit, arnebia root, bear gall, etc. through extracting liquid extract, filtering concentrating and pulverizing, or direct breaking, proportional mixing, adding auxiliaries, and loading in capsules. Its advantages include high curative rate, quickly taking its effect and convenient application.
Description
The present invention relates to a kind of new drug for the treatment of nephropathy and diabetes---after a kind of capsule ' Tangniaoshenkang ' for treating diabetes enters 21 century, diabetes and all kinds of urinary disorders have become another serious disease of harm humans life and health, therefore press in the society and a kind ofly can treat this type of disease, and instant effect, the cure rate height, the specific drug that the healing cycle is short.
The object of the present invention is to provide a kind of new drug that can treat this type of disease, and instant effect, cure rate height, short a kind of capsule ' Tangniaoshenkang ' for treating diabetes of healing cycle.
The object of the present invention is achieved like this: divide three parts to pulverize extraction, wherein the four flavor alcohol extractions of Radix Rubiae, Fructus Tribuli, Juniperus oxycedrus, Radix Arnebiae (Radix Lithospermi) are three times, merge three extracting liquid filterings, be condensed into cream, oven dry pulverizing, sieve; Fel Ursi, Calculus Bovis mortar porphyrize, Flos Carthami, Fructus Amomi Rotundus are broken into powder, sieve; All the other ten flavor medical material water are carried, and three extracting solution merge, filter, concentrate, oven dry, crushing screening.With alcohol, water extraction medicated powder, the former powder three part mixings of crude drug, interpolation adjuvant are made capsule.It is characterized in that its raw materials in part by weight is:
Fructus Chebulae 150-250g
Flos Carthami 50-150g
Fructus Amomi Rotundus 40-55g
Mumiyah-asil 40-80g
Folium Symplocoris Caudatae 60-100g
Lacca 60-100g
ZANGQIANCAO 60-100g
Fructus Phyllanthi 100-200g
Rhizoma Curcumae Longae 50-150g
Radix Berberidis Amurensis 50-150g
Fructus Tribuli 50-150g
Lapis Micae Aureus 20-40g
Juniperus oxycedrus 50-150g
Saxifraga umbellulata Hook.f.et Thoms. 60-100g
BAXIAGA 60-100g
Semen Canavaliae 40-80g
Fel Ursi 1-3g
Calculus Bovis 0.5-1.5g
A kind of capsule ' Tangniaoshenkang ' for treating diabetes of the present invention, its feature are that also its raw materials in part by weight is preferably:
Fructus Chebulae 200.0g
Flos Carthami 100.0g
Fructus Amomi Rotundus 49.0g
Mumiyah-asil 60.0g
Folium Symplocoris Caudatae 80.0g
Lacca 80.0g
ZANGQIANCAO 80.0g
Fructus Phyllanthi 150.0g
Rhizoma Curcumae Longae 100.0g
Radix Berberidis Amurensis 100.0g
Fructus Tribuli 100.0g
Lapis Micae Aureus 30.0g
Juniperus oxycedrus 100.0g
Saxifraga umbellulata Hook.f.et Thoms. 80.0g
BAXIAGA 80.0g
Semen Canavaliae 60.0g
Fel Ursi 2.0g
Calculus Bovis 1.0g
A kind of capsule ' Tangniaoshenkang ' for treating diabetes of the present invention has the function of " supplementing the kidney to control the nocturnal, diuresis ", in order to diseases such as treatment nephropathy, waist kidney pain, frequent micturition, turbid urine, diabetes, seminal emissions.And have the short characteristics of instant effect, cure rate height, healing cycle, for the patient removes the puzzlement that diseases of urinary system and diabetes are brought.
Below in conjunction with embodiment the present invention is described, the scheme of embodiment described here, do not limit the present invention, one of skill in the art can make improvements and change according to spirit of the present invention, described these improvement and variation all should be considered as in the scope of the present invention, and scope and spirit of the present invention are limited by claim:
Embodiment:
Get: Fructus Chebulae 200.0g
Flos Carthami 100.0g
Fructus Amomi Rotundus 49.0g
Mumiyah-asil 60.0g
Folium Symplocoris Caudatae 80.0g
Lacca 80.0g
ZANGQIANCAO 80.0g
Fructus Phyllanthi 150.0g
Rhizoma Curcumae Longae 100.0g
Radix Berberidis Amurensis 100.0g
Fructus Tribuli 100.0g
Lapis Micae Aureus 30.0g
Juniperus oxycedrus 100.0g
Saxifraga umbellulata Hook.f.et Thoms. 80.0g
BAXIAGA 80.0g
Semen Canavaliae 60.0g
Fel Ursi 2.0g
Calculus Bovis 1.0g.
And get 18 in prescription flavor medical material, and divide three parts to pulverize extraction, wherein Radix Rubiae, Fructus Tribuli, Juniperus oxycedrus, Radix Arnebiae (Radix Lithospermi) four flavor alcohol extractions are three times, merge three extracting liquid filterings, be condensed into cream, oven dry pulverizing, sieve; Energy gallbladder, Calculus Bovis mortar porphyrize, Flos Carthami, Fructus Amomi Rotundus are broken into powder, sieve; All the other ten flavor medical material water are carried, and three extracting solution merge, filter, concentrate, oven dry, crushing screening.With alcohol, water extraction medicated powder, the former powder three part mixings of crude drug, interpolation adjuvant are made 500 capsules, promptly get product of the present invention.
Claims (3)
1, a kind of preparation method of capsule ' Tangniaoshenkang ' for treating diabetes new drug: the flavor of 18 in prescription medical material, divide three parts to pulverize extraction, wherein the four flavor alcohol extractions of Radix Rubiae, Fructus Tribuli, Juniperus oxycedrus, Radix Arnebiae (Radix Lithospermi) are three times, merge three extracting liquid filterings, be condensed into cream, oven dry pulverizing, sieve; Fel Ursi, Calculus Bovis mortar porphyrize, Flos Carthami, Fructus Amomi Rotundus are broken into powder, sieve; All the other ten flavor medical material water are carried, and three times extracting solution merges, filters, concentrates, dries, morcels and sieve.With alcohol, water extraction medicated powder, the former powder three part mixings of crude drug, interpolation adjuvant are made capsule.It is characterized in that its raw materials in part by weight is:
Fructus Chebulae 150-250g
Flos Carthami 50-150g
Fructus Amomi Rotundus 40-55g
Mumiyah-asil 40-80g
Folium Symplocoris Caudatae 60-100g
Lacca 60-100g
ZANGQIANCAO 60-100g
Fructus Phyllanthi 100-200g
Rhizoma Curcumae Longae 50-150g
Radix Berberidis Amurensis 50-150g
Fructus Tribuli 50-150g
Lapis Micae Aureus 20-40g
Juniperus oxycedrus 50-150g
Saxifraga umbellulata Hook.f.et Thoms. 60-100g
BAXIAGA 60-100g
Semen Canavaliae 40-80g
Fel Ursi 1-3g
Calculus Bovis 0.5-1.5g
2, according to the capsule ' Tangniaoshenkang ' for treating diabetes of claim 1, its feature is that also its raw materials in part by weight is preferably:
Fructus Chebulae 200.0g
Flos Carthami 100.0g
Fructus Amomi Rotundus 49.0g
Mumiyah-asil 60.0g
Folium Symplocoris Caudatae 80.0g
Lacca 80.0g
ZANGQIANCAO 80.0g
Fructus Phyllanthi 150.0g
Rhizoma Curcumae Longae 100.0g
Radix Berberidis Amurensis 100.0g
Fructus Tribuli 100.0g
Lapis Micae Aureus 30.0g
Juniperus oxycedrus 100.0g
Saxifraga umbellulata Hook.f.et Thoms. 80.0g
BAXIAGA 80.0g
Semen Canavaliae 60.0g
Fel Ursi 2.0g
Calculus Bovis 1.0g
3, according to claim 1 or the 2 a kind of new drugs that prepare.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100442 CN1356117A (en) | 2001-01-11 | 2001-01-11 | Capsule 'Tangniaoshenkang' for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100442 CN1356117A (en) | 2001-01-11 | 2001-01-11 | Capsule 'Tangniaoshenkang' for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1356117A true CN1356117A (en) | 2002-07-03 |
Family
ID=4651594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01100442 Pending CN1356117A (en) | 2001-01-11 | 2001-01-11 | Capsule 'Tangniaoshenkang' for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1356117A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100482249C (en) * | 2004-02-11 | 2009-04-29 | 吴芳 | Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat nephrotic syndrome |
| CN100482248C (en) * | 2004-02-11 | 2009-04-29 | 吴芳 | Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat diabetic nephropathy |
| CN105343753A (en) * | 2015-12-15 | 2016-02-24 | 史志东 | Traditional Chinese medicinal composition for treating diabetes |
| CN105477436A (en) * | 2016-01-22 | 2016-04-13 | 久美彭措 | Method for preparing Tibetan medicine for treating children nephrosis |
-
2001
- 2001-01-11 CN CN 01100442 patent/CN1356117A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100482249C (en) * | 2004-02-11 | 2009-04-29 | 吴芳 | Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat nephrotic syndrome |
| CN100482248C (en) * | 2004-02-11 | 2009-04-29 | 吴芳 | Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat diabetic nephropathy |
| CN105343753A (en) * | 2015-12-15 | 2016-02-24 | 史志东 | Traditional Chinese medicinal composition for treating diabetes |
| CN105477436A (en) * | 2016-01-22 | 2016-04-13 | 久美彭措 | Method for preparing Tibetan medicine for treating children nephrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1356117A (en) | Capsule 'Tangniaoshenkang' for treating diabetes | |
| CN1927279A (en) | Chinese medicine composition for treating skin disease | |
| CN1785391A (en) | Chinese medicinal composition and its preparation method | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN1272027C (en) | Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method | |
| CN1049586C (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN1772270A (en) | Tiantan prepn for treating kidney-yang deficiency diseases and its production process | |
| CN1083714A (en) | A kind of cancer therapy drug of Chinese medicinal components | |
| CN1686414A (en) | Wound dispelling swell dispersing tincture and its preparation method | |
| CN1116890C (en) | Medicine for treating hepatitis B | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN1768803A (en) | Medicine for treating hypertension and its preparing process | |
| CN1872136A (en) | Medication for treating neonatal jaundice, and method of use. | |
| CN1965924A (en) | Medicament for lowering blood fat and dilating coronary artery | |
| CN1186028C (en) | Antagesic Chinese medicine and its preparing process and usage | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
| CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
| CN1144123A (en) | Xinmaitai prescription and producing process thereof | |
| CN1481876A (en) | Medication for virus hepatitis and hepatocirrhosis | |
| CN1879846A (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
| CN1562177A (en) | Chinese materia medica preparation for treating hysteromyoma and preparation method | |
| CN1281252C (en) | Medicinal composition for treating urinary lithiasis and its preparing method | |
| CN1127968C (en) | Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method | |
| CN1186036C (en) | Diabetes treating medicine and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |